ETHEX 237 (Hyoscyamine sulfate extended-release 0.375 mg)
Pill imprint ETHEX 237 has been identified as Hyoscyamine sulfate extended-release 0.375 mg.
Hyoscyamine is used in the treatment of irritable bowel syndrome; crohn's disease; anesthesia; urinary incontinence; endoscopy or radiology premedication and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy. Hyoscyamine 0.375 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- ETHEX 237
- Strength:
- 0.375 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Anticholinergics/antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0237
More about hyoscyamine
Consumer resources
- Hyoscyamine
- Hyoscyamine controlled-release tablets
- Hyoscyamine drops
- Hyoscyamine elixir
- Hyoscyamine extended-release capsules
- More (5) »
- Other brands: Levsin, Levbid, Levsin SL, Anaspaz, More (20) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
